| Dr Gowtham Adamane Rao, MD, PHD | |
|
1 Johnson And Johnson Plz, New Brunswick, NJ 08933-8320 | |
| (803) 386-7890 | |
| Not Available |
| Full Name | Dr Gowtham Adamane Rao |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 1 Johnson And Johnson Plz, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457397788 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gowtham Adamane Rao, MD, PHD 1 Johnson And Johnson Plz, New Brunswick, NJ 08933-0002 Ph: (803) 386-7890 | Dr Gowtham Adamane Rao, MD, PHD 1 Johnson And Johnson Plz, New Brunswick, NJ 08933-8320 Ph: (803) 386-7890 |
News Archive
Janssen-Cilag International NV announced today that the European Commission has approved the marketing authorisation for DACOGEN(decitabine) for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukaemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.
University of Toronto (U of T) researchers are proposing a new way of understanding Amyotrophic Lateral Sclerosis (ALS), the devastating and incurable neurological disease. Their findings, published today in the journal Neuron, could be a major milestone on the path to a treatment for both ALS and dementia.
A new study carried out by the World Health Organization and the Centers for Disease Control and Prevention (CDC) says that a historic milestone has been crossed – over 50% of the world's babies are now safe from rubella, or German measles. The disease has not been detected for a year or more in more than 80 countries all over the world.
Merck Canada Inc. announced today that KEYTRUDATM (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. KEYTRUDA is a humanized monoclonal antibody that works by increasing the ability of the body's immune system to fight advanced melanoma, the most serious form of skin cancer. It is the first of a new class of therapies called anti-PD-1s approved in Canada.
Men have a four times greater risk than women of developing abdominal aortic aneurysms, estimated to be the cause of death in 4 percent of people over the age of 65, but the mechanism for this higher incidence has remained unknown.
› Verified 4 days ago
Dov Levine, General Practice Medicare: Not Enrolled in Medicare Practice Location: 125 Paterson Street, Meb 596, New Brunswick, NJ 08901 Phone: 732-235-7674 | |
Dr. Nicodeme Wanko Agassy, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 240-715-7885 |